People
Clare O’Brien
Biography
Clare is global Life Sciences Sector Co-Lead and regularly advises major U.S. and international clients on their public and private mergers and acquisition transactions, including public company restructurings, joint ventures and large public transactions.
She also provides counsel on corporate law questions, including corporate governance matters.
Prior to joining the firm, Ms. O’Brien worked with the law firm of Brady & Tarpey, P.C., where her practice included cross-border corporate transactions, and litigation. She began her legal career at the Irish law firm of Eugene F. Collins & Son.
Practice areas
- Corporate and M&A
- M and A JVs and corporate reorganizations
- Private client
- Asset management M and A
- Capital markets
- Global employment and compensation
- Public company advisory and corporate governance
Sectors
- Life sciences and healthcare
- Capital solutions
- Consumer and retail
- Sovereign wealth and institutional investors
- Family office
- Defense
Selected experience
- Boston Scientific, a global medical technology leader, on its strategic investment in MiRus LLC, a privately held company developing and commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment of cardiovascular and orthopedic diseases, including the SIEGEL transcatheter aortic valve replacement system.
- Boston Scientific Corporation in various transactions, including its pending USD15 billion acquisition of Penumbra, its USD3.7bn acquisition of Axonics, its USD615m acquisition of Apollo Endosurgery, and its USD800m divestiture of BTG Specialty Pharmaceuticals to portfolio companies of Charterhouse Capital Partners.
- Atrion Corporation in its acquisition by Nordson Corporation for an aggregate equity value of approximately USD815m.
- Exscientia in its recently completed combination with Recursion.
- BioNTech in its acquisition of Biotheus.
- Mubadala Capital, established as the financial investment arm of Mubadala Development Company, in various transactions, including its 2022 acquisition of Canada Cartage Corporation and its recently completed acquisition, together with members of Fortress management, of all of the indirect interests in Fortress Investment Group LLC.
- Mubadala Investment Company, a public joint stock company wholly owned by the Government of the Emirate of Abu Dhabi, in various transactions, including its global business partnership with General Electric Company, its investment in the EBX Group (and related restructuring transactions), its investment with Trafigura Pte. Ltd. In MMX Porte Sudeste and in connection with the establishment of several private lending programs with global financial institution origination partners, which provide financing solutions to U.S. and European middle-market businesses.
- Ardagh Group in various transactions, including its USD8.3bn “de-SPAC” transaction involving the combination of its metal packaging business with Gores Holdings V, Inc., a special purpose acquisition company, the combination of its Food & Specialty Metal Packaging business with the packaging business of Element Holdings II L.P., an entity controlled by The Ontario Teachers' Pension Plan, to form Trivium Packaging, its acquisition of certain metal beverage can manufacturing assets from Ball Corporation and Rexam PLC with an enterprise value of USD3.42bn, and its sale of Anchor Glass Container Corporation to an affiliate of KPS Capital Partners LP.
- Raytheon Company in various transactions, including its 2020 “merger of equals” combination with United Technologies Corporation.
Education
- B.S., Univ of Dublin Trinity College, 1982
- J.D., Ireland (Incorp. Law Soc. Of), 1985
Admissions
- New York State, 1986
- Irish Roll of Solicitors